HYPD Hyperion DeFi | $3.58 +8.5% | 9/8/2026 | | Boost Price Target | $7.30 ➝ $8.45 | Buy | 00.00% | View details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 9/8/2026 |
HIND Vyome | $2.09 -5.9% | 9/3/2026 | | Initiated Coverage | $3.50 | Buy | 00.00% | View details for Chardan Capital rating of Vyome (NASDAQ:HIND) on 9/3/2026 |
HIND Vyome | $2.09 -5.9% | 9/3/2026 | | Initiated Coverage | $3.50 | Buy | 00.00% | View details for Chardan Capital rating of Vyome (NASDAQ:HIND) on 9/3/2026 |
RCKT Rocket Pharmaceuticals | $3.71 -3.9% | 9/1/2026 | | Initiated Coverage | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/1/2026 |
ARWR Arrowhead Pharmaceuticals | $85.11 -1.4% | 8/31/2026 | | Reiterated Rating | $115.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 8/31/2026 |
PURR Hyperliquid Strategies | $11.93 -2.1% | 8/28/2026 | | Boost Price Target | $9.75 ➝ $17.00 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 8/28/2026 |
PURR Hyperliquid Strategies | $11.93 -2.1% | 8/27/2026 | | Reiterated Rating | $9.75 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 8/27/2026 |
ODYS Odysight.ai | $3.63 -3.7% | 8/26/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Odysight.ai (NASDAQ:ODYS) on 8/26/2026 |
QMLS QumulusAI | $6.66 +12.9% | 8/26/2026 | | Reiterated Rating | $24.50 | Buy | 00.00% | View details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 8/26/2026 |
RANI Rani Therapeutics | $0.87 +0.8% | 8/26/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 8/26/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
ZOOZ ZOOZ Power | $6.95 -10.2% | 8/26/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for Chardan Capital rating of ZOOZ Power (NASDAQ:ZOOZ) on 8/26/2026 |
PRME Prime Medicine | $3.56 -3.8% | 8/25/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 8/25/2026 |
PRME Prime Medicine | $3.56 -3.8% | 8/25/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Chardan Capital rating of Prime Medicine (NASDAQ:PRME) on 8/25/2026 |
EYPT Eyepoint Pharmaceuticals | $4.56 -0.4% | 8/18/2026 | | Downgrade | $5.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/18/2026 |
RANI Rani Therapeutics | $0.87 +0.8% | 8/18/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Chardan Capital rating of Rani Therapeutics (NASDAQ:RANI) on 8/18/2026 |
EYPT Eyepoint Pharmaceuticals | $4.56 -0.4% | 8/17/2026 | | Reiterated Rating | $65.00 ➝ $5.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/17/2026 |
HIVE HIVE Digital Technologies | $3.15 +1.3% | 8/17/2026 | | Reiterated Rating | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 8/17/2026 |
ODYS Odysight.ai | $3.63 -3.7% | 8/17/2026 | | Initiated Coverage | $7.15 | Buy | 00.00% | View details for Chardan Capital rating of Odysight.ai (NASDAQ:ODYS) on 8/17/2026 |
COYA Coya Therapeutics | $4.61 -3.2% | 8/12/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 8/12/2026 |
QMLS QumulusAI | $6.66 +12.9% | 8/12/2026 | | Initiated Coverage | $24.50 | Buy | 00.00% | View details for Chardan Capital rating of QumulusAI (NASDAQ:QMLS) on 8/12/2026 |
VFS VinFast Auto | $3.10 +0.6% | 8/12/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 8/12/2026 |
HYPD Hyperion DeFi | $3.58 +8.5% | 8/11/2026 | | Reiterated Rating | $7.30 | Buy | 00.00% | View details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 8/11/2026 |
TENX Tenax Therapeutics | $1.98 +2.1% | 8/11/2026 | | Downgrade | $5.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026 |
CLSK Cleanspark | $13.48 +6.2% | 8/10/2026 | | Reiterated Rating | $21.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 8/10/2026 |
EYPT Eyepoint Pharmaceuticals | $4.56 -0.4% | 8/7/2026 | | Reiterated Rating | $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 8/7/2026 |
GLXY Galaxy Digital | $27.05 +2.7% | 8/5/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 8/5/2026 |
WULF TeraWulf | $17.86 +8.2% | 8/5/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 8/5/2026 |
CIFR Cipher Mining | $18.51 +4.3% | 8/4/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 8/4/2026 |
OCUL Ocular Therapeutix | $11.37 +6.9% | 8/4/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 8/4/2026 |
STOK Stoke Therapeutics | $30.05 +0.8% | 8/4/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Stoke Therapeutics (NASDAQ:STOK) on 8/4/2026 |
CRVO CervoMed | $2.53 -1.2% | 8/3/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of CervoMed (NASDAQ:CRVO) on 8/3/2026 |
IMRX Immuneering | $4.78 -0.8% | 8/3/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 8/3/2026 |
KRYS Krystal Biotech | $351.26 -1.9% | 8/3/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Krystal Biotech (NASDAQ:KRYS) on 8/3/2026 |
ALNY Alnylam Pharmaceuticals | $260.10 -2.3% | 7/31/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Chardan Capital rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/31/2026 |
TENX Tenax Therapeutics | $1.98 +2.1% | 7/31/2026 | | Reiterated Rating | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 7/31/2026 |
CLSK Cleanspark | $13.48 +6.2% | 7/28/2026 | | Boost Price Target | $19.00 ➝ $21.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/28/2026 |
FDMT 4D Molecular Therapeutics | $14.63 -2.3% | 7/28/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/28/2026 |
LXEO Lexeo Therapeutics | $4.76 -2.7% | 7/28/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 7/28/2026 |
PVLA Palvella Therapeutics | $152.28 -3.2% | 7/28/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 7/28/2026 |
PMN Promis Neurosciences | $12.53 -0.6% | 7/27/2026 | | Set Price Target | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Promis Neurosciences (NASDAQ:PMN) on 7/27/2026 |
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
HIVE HIVE Digital Technologies | $3.15 +1.3% | 7/27/2026 | | Initiated Coverage | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 7/27/2026 |
CIFR Cipher Mining | $18.51 +4.3% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 7/27/2026 |
WULF TeraWulf | $17.86 +8.2% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 7/27/2026 |
CIFR Cipher Mining | $18.51 +4.3% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of Cipher Mining (NASDAQ:CIFR) on 7/27/2026 |
HIVE HIVE Digital Technologies | $3.15 +1.3% | 7/27/2026 | | Initiated Coverage | $7.50 | Buy | 00.00% | View details for Chardan Capital rating of HIVE Digital Technologies (NASDAQ:HIVE) on 7/27/2026 |
PMN Promis Neurosciences | $12.53 -0.6% | 7/27/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Promis Neurosciences (NASDAQ:PMN) on 7/27/2026 |
WULF TeraWulf | $17.86 +8.2% | 7/27/2026 | | Initiated Coverage | $32.00 | Buy | 00.00% | View details for Chardan Capital rating of TeraWulf (NASDAQ:WULF) on 7/27/2026 |
ARWR Arrowhead Pharmaceuticals | $85.11 -1.4% | 7/22/2026 | | Boost Price Target | $90.00 ➝ $115.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/22/2026 |
CLSK Cleanspark | $13.48 +6.2% | 7/15/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/15/2026 |
CLSK Cleanspark | $13.48 +6.2% | 7/8/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 7/8/2026 |
MGX Metagenomi | $1.16 -0.9% | 7/7/2026 | | Initiated Coverage | $7.00 ➝ $5.00 | Buy | 00.00% | View details for Chardan Capital rating of Metagenomi (NASDAQ:MGX) on 7/7/2026 |
IRD Opus Genetics | $4.34 -7.1% | 7/6/2026 | | Reiterated Rating | $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 7/6/2026 |
IBIO iBio | $1.30 -0.8% | 7/2/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NASDAQ:IBIO) on 7/2/2026 |
TENX Tenax Therapeutics | $1.98 +2.1% | 7/2/2026 | | Reiterated Rating | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 7/2/2026 |
EYPT Eyepoint Pharmaceuticals | $4.56 -0.4% | 7/1/2026 | | Boost Price Target | $29.00 ➝ $65.00 | Buy | 00.00% | View details for Chardan Capital rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 7/1/2026 |
ARWR Arrowhead Pharmaceuticals | $85.11 -1.4% | 6/30/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for Chardan Capital rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 6/30/2026 |
PRQR ProQR Therapeutics | $2.05 -1.0% | 6/26/2026 | | Lower Price Target | $4.00 ➝ $3.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 6/26/2026 |
OCUL Ocular Therapeutix | $11.37 +6.9% | 6/25/2026 | | Boost Price Target | $21.00 ➝ $23.00 | Buy | 00.00% | View details for Chardan Capital rating of Ocular Therapeutix (NASDAQ:OCUL) on 6/25/2026 |
TENX Tenax Therapeutics | $1.98 +2.1% | 6/22/2026 | | Initiated Coverage | $27.00 | Buy | 00.00% | View details for Chardan Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 6/22/2026 |
IRD Opus Genetics | $4.34 -7.1% | 6/18/2026 | | Boost Price Target | $11.00 ➝ $13.00 | Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 6/18/2026 |
IRD Opus Genetics | $4.34 -7.1% | 6/17/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Opus Genetics (NASDAQ:IRD) on 6/17/2026 |
SABS SAB Biotherapeutics | $3.63 -2.4% | 6/17/2026 | | Boost Price Target | $14.00 ➝ $16.00 | Buy | 00.00% | View details for Chardan Capital rating of SAB Biotherapeutics (NASDAQ:SABS) on 6/17/2026 |
COYA Coya Therapeutics | $4.61 -3.2% | 6/12/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Coya Therapeutics (NASDAQ:COYA) on 6/12/2026 |
PURR Hyperliquid Strategies | $11.93 -2.1% | 6/12/2026 | | Reiterated Rating | $9.75 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 6/12/2026 |
ZOOZ ZOOZ Power | $6.95 -10.2% | 6/12/2026 | | Lower Price Target | $40.00 ➝ $10.00 | Buy | 00.00% | View details for Chardan Capital rating of ZOOZ Power (NASDAQ:ZOOZ) on 6/12/2026 |
CAMP CAMP4 Therapeutics | $4.40 -0.2% | 6/10/2026 | | Set Price Target | $6.50 | Buy | 00.00% | View details for Chardan Capital rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 6/10/2026 |
CAMP CAMP4 Therapeutics | $4.40 -0.2% | 6/10/2026 | | Initiated Coverage | $6.50 | Buy | 00.00% | View details for Chardan Capital rating of CAMP4 Therapeutics (NASDAQ:CAMP) on 6/10/2026 |
PHMMF Pharma Mar | $94.60
| 6/9/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Pharma Mar (OTCMKTS:PHMMF) on 6/9/2026 |
VFS VinFast Auto | $3.10 +0.6% | 6/9/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 6/9/2026 |
CLSK Cleanspark | $13.48 +6.2% | 6/8/2026 | | Boost Price Target | $16.00 ➝ $19.00 | Buy | 00.00% | View details for Chardan Capital rating of Cleanspark (NASDAQ:CLSK) on 6/8/2026 |
HYPD Hyperion DeFi | $3.58 +8.5% | 6/8/2026 | | Lower Price Target | $8.25 ➝ $7.30 | Buy | 00.00% | View details for Chardan Capital rating of Hyperion DeFi (NASDAQ:HYPD) on 6/8/2026 |
KEEL Keel Infrastructure | $3.73 +7.5% | 6/8/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 6/8/2026 |
PVLA Palvella Therapeutics | $152.28 -3.2% | 5/21/2026 | | Reiterated Rating | $240.00 | Buy | 00.00% | View details for Chardan Capital rating of Palvella Therapeutics (NASDAQ:PVLA) on 5/21/2026 |
PURR Hyperliquid Strategies | $11.93 -2.1% | 5/20/2026 | | Boost Price Target | $8.45 ➝ $9.75 | Buy | 00.00% | View details for Chardan Capital rating of Hyperliquid Strategies (NASDAQ:PURR) on 5/20/2026 |
ALMS Alumis | $10.58 -4.7% | 5/19/2026 | | Boost Price Target | $38.00 ➝ $40.00 | Buy | 00.00% | View details for Chardan Capital rating of Alumis (NASDAQ:ALMS) on 5/19/2026 |
IMRX Immuneering | $4.78 -0.8% | 5/19/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Chardan Capital rating of Immuneering (NASDAQ:IMRX) on 5/19/2026 |
IMTX Immatics | $9.44 -1.3% | 5/19/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for Chardan Capital rating of Immatics (NASDAQ:IMTX) on 5/19/2026 |
KEEL Keel Infrastructure | $3.73 +7.5% | 5/11/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 5/11/2026 |
KOD Kodiak Sciences | $35.07 -0.8% | 5/11/2026 | | Upgrade | $14.00 ➝ $61.00 | Neutral ➝ Buy | 00.00% | View details for Chardan Capital rating of Kodiak Sciences (NASDAQ:KOD) on 5/11/2026 |
LXEO Lexeo Therapeutics | $4.76 -2.7% | 5/11/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for Chardan Capital rating of Lexeo Therapeutics (NASDAQ:LXEO) on 5/11/2026 |
RCKT Rocket Pharmaceuticals | $3.71 -3.9% | 5/11/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for Chardan Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 5/11/2026 |
KDK Kodiak AI | $3.89 +1.8% | 5/8/2026 | | Lower Price Target | $22.00 ➝ $15.00 | Buy | 00.00% | View details for Chardan Capital rating of Kodiak AI (NASDAQ:KDK) on 5/8/2026 |
IOVA Iovance Biotherapeutics | $8.70 -1.0% | 5/7/2026 | | Lower Price Target | $16.00 ➝ $14.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/7/2026 |
CLYM Climb Bio | $15.90 +2.4% | 5/5/2026 | | Initiated Coverage | $22.00 | Buy | 00.00% | View details for Chardan Capital rating of Climb Bio (NASDAQ:CLYM) on 5/5/2026 |
EDIT Editas Medicine | $3.03 -6.2% | 5/5/2026 | | Boost Price Target | $3.50 ➝ $4.00 | Buy | 00.00% | View details for Chardan Capital rating of Editas Medicine (NASDAQ:EDIT) on 5/5/2026 |
GLXY Galaxy Digital | $27.05 +2.7% | 5/4/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 5/4/2026 |
KEEL Keel Infrastructure | $3.73 +7.5% | 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 5/4/2026 |
RIOT Riot Platforms | $22.26 +2.1% | 5/4/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Chardan Capital rating of Riot Platforms (NASDAQ:RIOT) on 5/4/2026 |
QURE uniQure | $45.68 +2.7% | 4/30/2026 | | Boost Price Target | $31.00 ➝ $37.00 | Buy | 00.00% | View details for Chardan Capital rating of uniQure (NASDAQ:QURE) on 4/30/2026 |
RIOT Riot Platforms | $22.26 +2.1% | 4/27/2026 | | Initiated Coverage | $27.50 | Buy | 00.00% | View details for Chardan Capital rating of Riot Platforms (NASDAQ:RIOT) on 4/27/2026 |
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date |
GLXY Galaxy Digital | $27.05 +2.7% | 4/27/2026 | | Initiated Coverage | $35.00 | Buy | 00.00% | View details for Chardan Capital rating of Galaxy Digital (NASDAQ:GLXY) on 4/27/2026 |
KEEL Keel Infrastructure | $3.73 +7.5% | 4/27/2026 | | Initiated Coverage | $4.50 | Buy | 00.00% | View details for Chardan Capital rating of Keel Infrastructure (NASDAQ:KEEL) on 4/27/2026 |
NTLA Intellia Therapeutics | $12.74
| 4/27/2026 | | Boost Price Target | $27.00 ➝ $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Intellia Therapeutics (NASDAQ:NTLA) on 4/27/2026 |
VFS VinFast Auto | $3.10 +0.6% | 4/23/2026 | | Reiterated Rating | $5.50 | Buy | 00.00% | View details for Chardan Capital rating of VinFast Auto (NASDAQ:VFS) on 4/23/2026 |
ANRO Alto Neuroscience | $35.75 +0.6% | 4/22/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for Chardan Capital rating of Alto Neuroscience (NYSE:ANRO) on 4/22/2026 |
PASG Passage Bio | $4.85 +4.3% | 4/21/2026 | | Set Price Target | $21.00 ➝ $7.00 | Buy ➝ Neutral | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 4/21/2026 |
PASG Passage Bio | $4.85 +4.3% | 4/21/2026 | | Downgrade | $21.00 ➝ $7.00 | Buy ➝ Hold | 00.00% | View details for Chardan Capital rating of Passage Bio (NASDAQ:PASG) on 4/21/2026 |
IOVA Iovance Biotherapeutics | $8.70 -1.0% | 4/10/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for Chardan Capital rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 4/10/2026 |
IBIO iBio | $1.30 -0.8% | 4/9/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for Chardan Capital rating of iBio (NASDAQ:IBIO) on 4/9/2026 |
PRQR ProQR Therapeutics | $2.05 -1.0% | 4/9/2026 | | Reiterated Rating | $4.00 | Buy | 00.00% | View details for Chardan Capital rating of ProQR Therapeutics (NASDAQ:PRQR) on 4/9/2026 |